Based on the KANGJI MED.HLDS DL-00001 stock forecast from 0 analysts, the average analyst target price for KANGJI MED.HLDS DL-00001 is not available over the next 12 months. KANGJI MED.HLDS DL-00001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of KANGJI MED.HLDS DL-00001 is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, KANGJI MED.HLDS DL-00001’s stock price was EUR 0.83. KANGJI MED.HLDS DL-00001’s stock price has changed by +8.50% over the past week, +6.41% over the past month and -27.19% over the last year.
No recent analyst target price found for KANGJI MED.HLDS DL-00001
No recent average analyst rating found for KANGJI MED.HLDS DL-00001
Company Overview KANGJI MED.HLDS DL-00001
Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and ultrasonic scalpels, as well as disposable suction and irrigation sets, and retrieval bags; and reusable trocars and reusable forceps. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors, hospitals, and other customers. Kangji Medical Holdings Limited was founded in 2004 and is headquartered in Hangzhou, China. Read Less
Kangji Medical Holdings Limited, an investment holding company, engages in the design, development, manufacture, and sale of minimally invasive surgical instruments and accessories in Mainland China and internationally. It offers disposable trocars, polymer ligation clips, dispos...Read More
Frequently Asked Questions About KANGJI MED.HLDS DL-00001 (50J:F) Stock
Stock Target Advisor's fundamental analysis for KANGJI MED.HLDS DL-00001's stock is Slightly Bearish.
50J:F stock's dividend yield is 21.95%.
Our analysis grades 50J:F stock's dividend yield at A+. This means that 50J:F stock's dividend yield is above 100% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this 50J:F may be a good dividend stock for its sector.
Unfortunately we do not have enough data on 50J:F's stock to indicate what its average analyst target is.
50J:F stock's Price/Earning ratio is 13.58.
Our analysis grades 50J:F stock's Price / Earning ratio at B+. This means that 50J:F stock's Price/Earning ratio is above 13% of the stocks in the Medical Instruments & Supplies sector in the F exchange.
Based on this 50J:F may be undervalued for its sector.
The last closing price of 50J:F's stock was EUR 0.83.
The most recent market capitalization for 50J:F is EUR 1.01B.
Unfortunately we do not have enough analyst data on 50J:F's stock to indicate whether its price will go up or not.
Following are ETFs with the highest allocation to KANGJI MED.HLDS DL-00001's stock :
As per our most recent records KANGJI MED.HLDS DL-00001 has 1,003 Employees.
KANGJI MED.HLDS DL-00001's registered address is Tonglu Economic Development Zone, Hangzhou, China, 311501.
You can get more information about it from KANGJI MED.HLDS DL-00001's website at https://www.kangjimedical.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 50J:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
